Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Gemma Pujol Muncunill"'
Autor:
María Clara Jijón Andrade, Gemma Pujol Muncunill, Ana Lozano Ruf, Laura Álvarez Carnero, Victor Vila Miravet, Dolores García Arenas, Natalia Egea Castillo, Javier Martín de Carpi
Publikováno v:
BMC Gastroenterology, Vol 23, Iss 1, Pp 1-7 (2023)
Abstract Background Recent trials suggested that the Crohn’s disease (CD) exclusion diet (CDED) plus partial enteral nutrition (PEN) is a safe and effective strategy in remission induction of paediatric-onset CD. However, real-world evidence regard
Externí odkaz:
https://doaj.org/article/21265cdd6f1b479d8c8bb3dfc3bbdb5d
Autor:
Santiago Jiménez Treviño, Gemma Pujol Muncunill, Rafael Martín-Masot, Alejandro Rodríguez Martínez, Oscar Segarra Cantón, Luis Peña Quintana, Honorio Armas Ramos, Francisco Javier Eizaguirre Arocena, Josefa Barrio Torres, José Ignacio García Burriel, Luis Ortigosa Castillo, Ester Donat Aliaga, Vanesa Crujeiras Martínez, Patricia Barros García, Gonzalo Botija Arcos, Juan Manuel Bartolomé Porro, Mercedes Juste Ruiz, Carlos Ochoa Sangrador, Zuriñe García Casales, Gonzalo Galicia Poblet, Pablo Oliver Goicolea, Helena Lorenzo Garrido, Ruth García Romero, Enrique La Orden Izquierdo, David Pérez Solis, Víctor Manuel Navas-López, Juan José Díaz Martin, Javier Martín de Carpi
Publikováno v:
Frontiers in Pediatrics, Vol 8 (2020)
Background and Aims: Diagnostic delay (DD) is especially relevant in children with inflammatory bowel disease, leading to potential complications. We examined the intervals and factors for DD in the pediatric population of Spain.Methods: We conducted
Externí odkaz:
https://doaj.org/article/4c0c4500331e4c79b3c4e00860c46fc8
Autor:
Alicia Isabel Pascual Pérez, Gemma Pujol Muncunill, Patricia Domínguez Sánchez, Sara Feo Ortega, Javier Martín de Carpi
Publikováno v:
Anales de Pediatría, Vol 94, Iss 4, Pp 252-253 (2021)
Externí odkaz:
https://doaj.org/article/8ba675513ae44949bd1050b530a85b8c
Autor:
Alicia Isabel Pascual Pérez, Gemma Pujol Muncunill, Patricia Domínguez Sánchez, Sara Feo Ortega, Javier Martín de Carpi
Publikováno v:
Anales de Pediatría (English Edition), Vol 94, Iss 4, Pp 252-253 (2021)
Externí odkaz:
https://doaj.org/article/a1be826fe41c41cc814a1da386ffef5a
Autor:
Javier Martín-de-Carpi, Santiago Jiménez Treviño, Gemma Pujol Muncunill, Rafael Martín-Masot, Víctor Manuel Navas-López
Publikováno v:
Anales de Pediatría, Vol 92, Iss 4, Pp 242.e1-242.e9 (2020)
Resumen: La enfermedad inflamatoria intestinal pediátrica continúa siendo poco prevalente en nuestro medio. El comienzo de los síntomas puede ser insidioso y el diagnóstico precoz permite disminuir las complicaciones y las secuelas de la enfermed
Externí odkaz:
https://doaj.org/article/f6ad8b25f82a4342b9b615cc15a31b6e
Autor:
Javier Martín-de-Carpi, Santiago Jiménez Treviño, Gemma Pujol Muncunill, Rafael Martín-Masot, Víctor Manuel Navas-López
Publikováno v:
Anales de Pediatría (English Edition), Vol 92, Iss 4, Pp 242.e1-242.e9 (2020)
Paediatric inflammatory bowel disease is not very common in Spain. Its onset can be silent and an early diagnosis reduces complications and sequelae related to the disease, and can improve the prognosis. It is advisable to define the different interv
Externí odkaz:
https://doaj.org/article/1f3dbd44410e4581837a6864adb49afc
Autor:
Víctor Manuel Navas-López, Gemma Pujol Muncunill, Enrique Llerena, María Navalón Rubio, David Gil-Ortega, Vicente Varea-Calderón, Carlos Sierra Salinas, Javier Martin-de-Carpi
Publikováno v:
Anales de Pediatría, Vol 88, Iss 2, Pp 89-99 (2018)
Resumen: Introducción y objetivos: Adalimumab (ADA), anticuerpo anti-TNF-α monoclonal recombinante de origen humano, generalmente se emplea como tratamiento de segunda línea en niños con enfermedad de Crohn (EC) que no han respondido o han perdid
Externí odkaz:
https://doaj.org/article/2a51f5ebcd2c4d2d83f6d5f3cdf06fca
Autor:
Anat Yerushalmy-Feler, Gemma Pujol-Muncunill, Javier Martin-de-Carpi, Kaija-Leena Kolho, Arie Levine, Christine Olbjørn, Maya Granot, Matteo Bramuzzo, Helena Rolandsdotter, Natalia Mouratidou, Ondrej Hradsky, Luca Scarallo, Manar Matar, Ramit Magen Rimon, Firas Rinawi, Tzippi Shalem, Hisham Najajra, Tim de Meij, Marina Aloi, Marta Velasco Rodríguez-Belvís, Patrizia Alvisi, Anna-Maria Schneider, Patrick van Rheenen, Víctor Manuel Navas-López, Fevronia Kiparissi, Josefa Barrio, Dan Turner, Shlomi Cohen
Publikováno v:
Journal of Pediatric Gastroenterology and Nutrition, 75(6), 717-723. Lippincott Williams and Wilkins
Yerushalmy-Feler, A, Pujol-Muncunill, G, Martin-de-Carpi, J, Kolho, K-L, Levine, A, Olbjørn, C, Granot, M, Bramuzzo, M, Rolandsdotter, H, Mouratidou, N, Hradsky, O, Scarallo, L, Matar, M, Rimon, R M, Rinawi, F, Shalem, T, Najajra, H, de Meij, T, Aloi, M, Rodríguez-Belvís, M V, Alvisi, P, Schneider, A-M, van Rheenen, P, Navas-López, V C M, Kiparissi, F, Barrio, J, Turner, D & Cohen, S 2022, ' Safety and Potential Efficacy of Escalating Dose of Ustekinumab in Pediatric Crohn Disease (the Speed-up Study) : A Multicenter Study from the Pediatric IBD Porto Group of ESPGHAN ', Journal of Pediatric Gastroenterology and Nutrition, vol. 75, no. 6, pp. 717-723 . https://doi.org/10.1097/MPG.0000000000003608
Yerushalmy-Feler, A, Pujol-Muncunill, G, Martin-de-Carpi, J, Kolho, K-L, Levine, A, Olbjørn, C, Granot, M, Bramuzzo, M, Rolandsdotter, H, Mouratidou, N, Hradsky, O, Scarallo, L, Matar, M, Rimon, R M, Rinawi, F, Shalem, T, Najajra, H, de Meij, T, Aloi, M, Rodríguez-Belvís, M V, Alvisi, P, Schneider, A-M, van Rheenen, P, Navas-López, V C M, Kiparissi, F, Barrio, J, Turner, D & Cohen, S 2022, ' Safety and Potential Efficacy of Escalating Dose of Ustekinumab in Pediatric Crohn Disease (the Speed-up Study) : A Multicenter Study from the Pediatric IBD Porto Group of ESPGHAN ', Journal of Pediatric Gastroenterology and Nutrition, vol. 75, no. 6, pp. 717-723 . https://doi.org/10.1097/MPG.0000000000003608
OBJECTIVES: Escalation of the ustekinumab (UST) maintenance dosage was effective in adults with Crohn disease (CD), but no data are available for children. We evaluated the effectiveness and safety of dose escalation of UST in pediatric CD. METHODS:
Autor:
Ohad Atia, Gemma Pujol‐Muncunill, Víctor Manuel Navas‐López, Esther Orlanski‐Meyer, Oren Ledder, Raffi Lev‐Tzion, Gili Focht, Eyal Shteyer, Ronen Stein, Marina Aloi, Richard K. Russell, Javier Martin‐de‐Carpi, Dan Turner
Publikováno v:
Alimentary pharmacologytherapeutics. 56(5)
Patients enrolled in randomised controlled trials (RCTs) may differ from the target population due to restricted eligibility criteria. To compare treatment response to biologics in routine practice for children with inflammatory bowel diseases (IBD)
Autor:
Cristina Rubín de Célix, Javier Martín-de-Carpi, Gemma Pujol-Muncunill, Laura María Palomino, Marta Velasco Rodríguez-Belvís, Rafael Martín-Masot, Víctor Manuel Navas-López, Elena Ricart, María José Casanova, Alejandro Rodríguez Martínez, Eduardo Leo-Carnerero, Alba Alcaraz, Miriam Mañosa, Vicent Hernández, María Consuelo Cobelas Cobelas, César Sánchez, Luis Menchén, Francisco Mesonero, Manuel Barreiro-De Acosta, Nazareth Martínon, Coral Tejido Sandoval, Alicia Rendo Vázquez, Pilar Corsino, Raquel Vicente, Alejandro Hernández-Camba, José Ramón Alberto Alonso, I. Alonso-Abreu, Ana María Castro Millán, Laia Peries Reverter, Beatriz Castro, Estela Fernández-Salgado, M Mercedes Busto Cuiñas, José Manuel Benítez, Lucía Madero, Fernando Clemente, Sabino Riestra, Santiago Jiménez- Treviño, Maia Boscá-Watts, Elena Crehuá-Gaudiza, Marta Calvo Moya, José María Huguet, Ester-María Largo-Blanco, Leticia González Vives, Rocío Plaza, Iván Guerra, Josefa Barrio, Laura Escartín, Erika Alfambra, Noelia Cruz, M Carmen Muñoz, María Guadalupe Muñoz Pino, Manuel Van Domselaar, Belén Botella, David Monfort Miquel, M Carmen Rodríguez Grau, Agustín De La Mano, Yolanda Ber, María Calvo Iñiguez, Teresa de Jesús Martínez-Pérez, María Chaparro, Javier P. Gisbert
Publikováno v:
Gastroenterología y Hepatología. 46:S73